Every downstream microbiological result is only as reliable as the culture media on which it was performed. Patient safety and regulatory compliance are too important to be jeopardised by poor quality media.
RSSL provides GMP culture media quality control for media used in sterility testing, microbial limit testing, environmental monitoring or automated rapid sterility systems. From routine media qualification to facility specific isolates and bespoke protocols, our expert team of microbiologists will help you demonstrate media performance, reduce the risk of unreliable results and keep testing programmes moving.
GPT, inhibitory, indicative and sterility controls all included as standard on every project
Reference strains preserved below −70°C with full passage-limit traceability, independent of commercial inoculums
Your site-specific organisms received, preserved and stored for EM qualification as per Annex 1 requirements
Species-level identification of broth growth, confirming observed turbidity is the target organism.
Inoculation performed within a biological safety cabinet for high-value or contamination-sensitive media.
Culture media performance can directly affect the reliability of downstream microbiological testing. Qualification helps demonstrate that your media remains fit for purpose and can recover or differentiate the microorganisms intended to detect.
Culture media QC comprises of four tests which RSSL performs as a complete qualification suite. Testing is performed to Ph. Eur. 2.6.12, 2.6.13 and 2.6.27, USP <60>/<61>/<62> and JP 4.05/4.06. We will work with you to determine which tests and organisms apply based on your media type, intended use, and regulatory requirements.
Confirming the medium supports microbial growth at low inoculum levels
Confirming selective media suppress non-target organisms
Confirming differential media produce expected visual characteristics
Confirming the medium is not already contaminated
Culture media QC can support routine qualification, new media or supplier assessment and investigation of unexpected media performance. RSSL supports media used across a range of microbiological applications including:
We'll partner with you to ensure your testing requirements are met, offering additional support including:
A batch of medium that cannot adequately support microbial growth renders every negative result obtained on it untrustworthy. You would not know the test had failed to detect contamination until the media itself was retrospectively investigated, by which point product may already have been released.
A single batch can underpin dozens of sterility tests, microbial limit tests, or environmental monitoring results. A retrospective failure may trigger investigation, product hold, or withdrawal.
Culture media QC validates the foundation on which all your microbiological data is built.
| Service | Standard | Expedited |
|
Culture Media QC (full suite) |
10 working days | 6 working days |
|
Bespoke testing (e.g., Ph. Eur. 2.6.27, client-specific protocols) |
Agreed at project setup |
Agreed at project setup |
Contact us to discuss expedited scheduling for urgent batch release or investigation support.
Culture media QC is not just a formality. It is the reliable verification that supports every downstream microbiological result.
RSSL provides the complete qualification suite, performed under GMP, with the technical depth and regulatory specificity your QA programme requires.
Culture media performance directly affects the reliability of microbiological testing. If media does not support, inhibit or differentiate microorganisms as expected, the validity of the resulting data may be compromised.
Culture media QC helps demonstrate that media is fit for its intended use before it is used for product testing, environmental monitoring or aseptic process simulation.
The organisms depend on your media type and applicable pharmacopoeial requirements.
For example, non-selective agars such as TSA, the standard panel includes S. aureus, P. aeruginosa, B. subtilis, C. albicans, and A. brasiliensis. For selective media, organisms are dictated by Ph. Eur. 2.6.13 and USP <62>/<60>.
RSSL can incorporate client-supplied facility isolates or additional culture collection strains where your protocol requires it.
| Media format | Requirement |
| Plates/agars |
2 plates per organism per test (GPT or inhibitory); 1 plate for sterility control. |
|
Broths (Ph. Eur. 2.6.12/2.6.13) |
10 mL per organism per test + 10 mL sterility control; or 1 container per organism per test for smaller volumes |
|
Broths (Ph. Eur. 2.6.27) |
2 containers per organism per test |
EU GMP Annex 1 states that media QC should normally be performed by the end user. A supplier certificate of analysis confirms performance at manufacture but does not account for transport, storage or whether testing reflects your required pharmacopoeial standard.
RSSL can provide independent qualification to confirm your media remains fit for purpose.
Growth promotion testing confirms the medium supports microbial growth, independent of any product.
Method suitability testing validates the entire procedure in the presence of your specific product, determining whether it inhibits microbial recovery.
RSSL can support both culture media QC as a standalone service. Method suitability is available separately for MLT, sterility testing, endotoxin testing, and preservative efficacy testing.
Yes. RSSL can receive, preserve, and store your facility-specific environmental isolates at below -70°C. These organisms are then used alongside compendial reference strains when qualifying your EM media, directly addressing the EU GMP Annex 1 Section 10.9 requirement for representative local isolates. This is particularly valuable if you do not maintain your own culture collection.
Yes.
We accommodate client-specific specifications and acceptance criteria where these differ from or exceed pharmacopoeial requirements. If your protocol requires additional organisms, non-standard incubation conditions, or bespoke acceptance criteria, we will discuss feasibility at quotation stage and confirm scope in the project protocol.
Results outside the applicable acceptance criteria are investigated through RSSL's GMP quality system.
The investigation can assess factors including test execution, controls, media integrity and equipment performance. Where further investigation is required, our microbiologists can provide additional scientific support to help assess potential causes and determine the appropriate next steps.
The full suite is standard: growth promotion, inhibitory, indicative, and sterility controls, as appropriate for the media type. Most selective and differential media require the complete suite for compliant qualification per Ph. Eur. 2.6.13. If you submit non-selective media with no inhibitory or indicative function, testing is limited to what applies. Most competitors deliver GPT only.
Manufacturer QC confirms a batch met production specifications at the point of manufacture. User QC, which we perform on your behalf, verifies the media remains fit for purpose after transport and storage, tested to your required pharmacopoeial standard. As an independent laboratory with no commercial relationship to any media manufacturer, our results are free from the conflict of interest inherent in manufacturer self-certification.
